Navigation Links
Presentations at AHA expand on clinical utility of deCODE's DNA-based tests
Date:11/7/2008

Several presentations by deCODE genetics (Nasdaq:DCGN) scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests. These tests measure single-letter variations in the human genome (SNPs) on chromosomes 9p21 and 4q25 that deCODE has linked to increased risk of these cardiovascular conditions, enabling a better understanding of individual risk. As this information is independent of other conventional risk factors, these tests provide doctors in the clinic with a new tool for improving screening, prevention and treatment.

Important avenues for expanding the clinical utility of the deCODE tests to be discussed at the AHA meeting are summarized below. To assist those interested in learning more about deCODE's tests while onsite at AHA or to follow proceedings on the AHA Web site, www.americanheart.org, deCODE would like to note below the titles, time, date and locations listed. The full abstracts and contents of these talks are strictly embargoed for public dissemination until their time of presentation, as noted per AHA guidelines.

Myocardial infarction and 9p21 risk variants:

Several presentations focus on the 9p21 genetic risk markers for myocardial infarction (MI) that deCODE first reported in 2007 and which form the basis of the deCODE MI test for assessing individual risk as an aid in clinical practice. Individuals who have the at-risk versions of the SNPs detected by this test are 1.6- to 2-fold more likely to develop MI than are those with lowest risk genotypes, or at 1.3- to 1.5-fold higher risk than the general population. This level of risk is comparable to the risk due to highest qui
'/>"/>

Contact: Amy Speak
Amy.Speak@porternovelli.com
617-480-2708
deCODE genetics
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
2. ULURU Inc. Announces Poster Presentations at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
3. AdvaMed 2008 Opens Showcasing Latest Medical Technologies with Innovation Alley Exhibit and Next Generation Company Presentations
4. ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting
5. Neutral HIV presentations more likely to be considered inviting, study finds
6. Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008
7. ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations
8. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference
9. IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
10. Gen-Probe to Webcast Two Upcoming Investor Presentations
11. Seven Clinical Presentations on Tapentadol Immediate Release for Acute Pain to Be Featured at 2008 American Pain Society Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Magnatag’s new magnetic 365-Day attendance ... reduces vacation conflicts. A Manufacturing Manager from Augusta GA ... now employees and managers can check the board for ... is important to us and the board makes the ... seem harsh but it has made a difference.” ...
(Date:5/23/2013)... Magic often happens unexpectedly. "Howie Goes to ... twin five-year olds, Howie and his sister Heather, at ... in point. May 23, 2013 marks the debut of ... with the start of the Resort's "WeTime/MeTime” program, ... amenities and, most precious of all, opportunities for children and ...
(Date:5/23/2013)... Littleton, CO (PRWEB) May 23, 2013 ... environment, Special Operations Forces and law enforcement need an ... Night Vision Security Enhancer, Night VISER , is ... illuminator and motion sensing system to increase border and ... for Night VISER have more than tripled over the ...
(Date:5/23/2013)... DEER, Alberta (PRWEB) May 24, 2013 On ... in every nine women will hear in her lifetime: she ... My Knees: My Journey After a Breast Cancer Diagnosis ” ... days that followed. , Rideout drew from her daily journals ... like going through surgery, chemotherapy and radiation treatments to deal ...
(Date:5/23/2013)... Voyance, the ASC industry’s leading ... and ASCA, the industry’s national membership association, are ... Program. Voyance will leverage their decade ... experience to support ASCA’s goal to provide the ... , “Voyance is both excited and proud to ...
Breaking Medicine News(10 mins):Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:New Children's Comic Book, "Howie Goes to Maui," Launches May 23, 2013 On Four Seasons Resort Maui's Web Site 2Health News:New Children's Comic Book, "Howie Goes to Maui," Launches May 23, 2013 On Four Seasons Resort Maui's Web Site 3Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3Health News:Kimberley Rideout Shares Her Triumphant Cancer Survival Story 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3
... , WEDNESDAY, Jan. 11 (HealthDay News) -- The first ... cancer has been identified by scientists. Men who inherit the ... increased risk of developing prostate cancer, according to the study in ... Medicine . The HOXB13 gene plays an important role in ...
... 11 (HealthDay News) -- Researchers have identified a protein in ... exercise in mice. "There has been a feeling ... the body," said the study,s senior author, Bruce Spiegelman, a ... professor of cell biology at Harvard Medical School, in a ...
... Researchers have discovered that a subtype of leukemia characterized ... pathways distinctly different from a seemingly similar leukemia associated ... St. Jude Children,s Research Hospital Washington University Pediatric ... for treating patients with this more aggressive cancer. ...
... stent in a key artery in the neck is safer ... of carotid artery disease, according to a new study published ... A team of researchers led by Dr. Jon ... Wisconsin School of Medicine and Public Health, found the clinical ...
... By Madonna Behen HealthDay Reporter , WEDNESDAY, Jan. ... killer in the world, and only about 15 percent of ... treatable. But two preliminary studies that are scheduled to ... scientists are moving closer to developing new screening tests that ...
... condescendingly, excluded from a meeting, or ignored by a supervisor. ... depending on whether your co-worker is a man or a ... towards colleagues feel negative emotions especially when the incivility ... by Kathi Miner from Texas A&M University and Angela Eischeid ...
Cached Medicine News:Health News:Scientists Identify Inherited Prostate Cancer Gene 2Health News:Mouse Study Give Clues to Why Exercise Is Healthy 2Health News:Cancer sequencing project identifies potential approaches to combat aggressive leukemia 2Health News:Cancer sequencing project identifies potential approaches to combat aggressive leukemia 3Health News:Cancer sequencing project identifies potential approaches to combat aggressive leukemia 4Health News:Stenting for stroke prevention becoming safer in high-risk patients 2Health News:Tests Might Someday Help Spot Early Lung Cancer 2Health News:Tests Might Someday Help Spot Early Lung Cancer 3Health News:'I feel your pain ...' 2
(Date:5/23/2013)...   Direct to implant, or "one step," ... option for many women with BRCA (BReast CAncer) ... cancer risk, or with breast cancer. Traditionally, post-mastectomy ... second surgery to insert permanent implants, but immediate ... mastectomy can be a medically and cosmetically effective ...
(Date:5/23/2013)...  Net Medical Xpress Solutions, Inc., (OTC QB: NMXS), ... company has signed a letter of intent to acquire ... Huntsville, AL . MedTel Solutions is a ... recruitment of telemedicine physicians. Consideration for the acquisition will ... is expected by June 30, 2013. Dick ...
(Date:5/23/2013)... 23, 2013 Israel Brain Technologies (IBT) ... Israel,s 1 st International Brain ... -15 th in Tel Aviv , ... in the world by the Wall Street Journal ... Israel 2013 will showcase the latest breakthroughs in neuroscience and ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... , EMERYVILLE, Calif. , July 29 Bionovo, Inc. ... from the European Medicines Agency (EMA) in order to advance Menerba, the ... in Europe . The guidance defines the clinical and regulatory pathway ... , , ...
... joined 19 pro-life groups in a letter sent to Food and Drug Administration (FDA) Commissioner ... can cause abortions but is misleadingly labeled as an "emergency contraceptive," not be approved. ... Tom McClusky , FRC ... , , ...
Cached Medicine Technology:Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe 2Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe 3FRC Action and Pro-Life Coalition Urge the FDA to Reject New Abortion-Causing Drug 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: